EtiraRX, Inc.
Biotechnology company · Dallas, Texas, United States
EtiraRX, Inc. is a biotechnology company headquartered in Dallas, Texas, United States. Its earliest recorded incorporation is in 2021. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $2 million in total, most recently in 2021. It has reported private securities offerings to the US SEC, most recently $2.3 million sold in a notice filed in 2026.
EtiraRX at a glance
What does EtiraRX do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $2 million in total (2021). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $2.3 million sold (2026).
Frequently asked questions about EtiraRX
Where is EtiraRX headquartered?
EtiraRX, Inc. is headquartered in Dallas, Texas, United States.
What does EtiraRX do?
EtiraRX, Inc. is a biotechnology company.
When was EtiraRX founded?
The earliest incorporation on record for EtiraRX, Inc. is in 2021, according to public company registers.
Similar companies
- OncoNano Medicine, Inc.Dallas, Texas, United States
- Taysha Gene Therapies, Inc.Dallas, Texas, United States
- Sonara Health, Inc.Dallas, Texas, United States
- Instil Bio, Inc.Dallas, Texas, United States
- Stingray Therapeutics, Inc.Dallas, Texas, United States
- Qualia Oto, Inc.Dallas, Texas, United States
- CG Oncology, Inc.Dallas, Texas, United States
- BackStop Neural, Inc.Dallas, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences